Attovia Therapeutics, Inc. (ATTO)

CIK 2058707 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Attovia Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 8, 20264/A0001644888-26-000009
Oct 8, 20263/A0001654907-26-000008
Oct 8, 20264/A0001654907-26-000009
Oct 8, 20263/A0001644888-26-000008
Sep 2, 20268-K0001193125-26-380215
Sep 2, 202610-Q0001193125-26-380228
Aug 28, 20264/A0000886982-26-000522
Aug 28, 20264/A0001866174-26-000011
Aug 28, 20261440000891836-26-000065
Aug 13, 202640000886982-26-000495
Aug 13, 202640001866174-26-000009
Aug 12, 2026SCHEDULE 13G0001172661-26-003341
Aug 11, 2026SCHEDULE 13D0001231919-26-000857
Aug 10, 202640001193125-26-342487
Aug 10, 202640000905148-26-003548
Aug 7, 202640001104659-26-092867
Aug 7, 202640001193125-26-340173
Aug 6, 2026S-80001193125-26-336011
Aug 6, 202640002141590-26-000008
Aug 6, 202640002141655-26-000008
Aug 6, 202640002142262-26-000006
Aug 6, 202640001193125-26-338430
Aug 6, 202640001242882-26-000004
Aug 6, 202640001193125-26-338420
Aug 6, 20268-K0001193125-26-338037